Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Facile synthesis of Sarcochlamys pulcherrima mediated silver nanoparticles for antibacterial, antibiofilm, and network pharmacology evaluation
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 09 May 2026

Facile synthesis of Sarcochlamys pulcherrima mediated silver nanoparticles for antibacterial, antibiofilm, and network pharmacology evaluation

  • Anuva Samanta1,
  • Adarsha Ghosh1,
  • Southik Nandi1,
  • Soumyadeep Ghosh1,
  • Akash Gupta1,
  • Arijit Mondal1,
  • Rudranil Saha1,
  • Pranee Roy1,
  • Dibyarupa Pal2 &
  • …
  • Arindam Maity1 

Scientific Reports (2026) Cite this article

  • 673 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biochemistry
  • Biotechnology
  • Chemistry
  • Drug discovery
  • Microbiology
  • Nanoscience and technology

Abstract

Green synthesis of nanoparticles (NPs) has transpired as aneconomical, efficient and environmentally friendlycompared to conventional methods. In this study, Sarcochlamys pulcherrima leaf extract was made to be used as a natural reducing and capping agent to fabricate silver nanoparticles (sp-AgNPs), which were further evaluated for antibacterial and antibiofilm activities. The sp-AgNPs were synthesized via two ways; Heating at 80 °C and Non-heating methodsto evaluate the particle size difference on the antibacterial and antibiofilm efficacy.The sp-AgNPs were characterized using standard techniques ofUV–Vis spectroscopy, Energy Dispersive Spectroscopy (EDX), Dynamic Light Scattering (DLS), Zeta Potential, and Scanning Electron Microscopy (SEM). The colour change pre and post synthesis and subsequent characteristic UV–Vis peaks confirmed successful nanoparticle formation. Zeta and SEM analyses of sp-AgNPs revealed average sizes of 37.6–45.1 nm for Heat and 44.7–53.9 nm for Non-heatwith spherical, needle-like morphology. EDX confirmed the presence of silver ionin sp-AgNPs. Antibacterial assays against B.subtilis, S.aureus, P.aeruginosa, and E.coli showed inhibitory zones with both synthesis methods. The Minimum Inhibitory Concentration (MIC) and Maximum Bactericidal Concentration (MBC) for sp-AgNPs wereevaluated and antibiofilm activity performed.Superior biofilm inhibition of 67.51–83.14%was demonstrated by Non-heatingsynthesismethod compared to 50.93–73.76% reduction bythe heatmethod.Further, the Liquid Chromatography-Tandem Mass Spectroscopy (LC-MS/MS) data and Network pharmacology identified key antibacterial phytoconstituents targeting immune and metabolic pathways like AKT1, STAT3, and CASP3. Overall, this study demonstrates a facile green synthesis of sp-AgNPs with potent antibacterial and antibiofilm potential which can be harnessed for future biomedical applications.

Similar content being viewed by others

Silver nanoparticles synthesized from Sempervivum tectorum leaf extract show antibacterial activity against canine Staphylococcus pseudintermedius

Article Open access 31 March 2026

Silver nanoparticles derived from Streptomyces sp. YJD18 with multifunctional biomedical applications

Article Open access 25 May 2025

Biosynthesis and assessment of antibacterial and antioxidant activities of silver nanoparticles utilizing Cassia occidentalis L. seed

Article Open access 27 March 2024

Acknowledgements

The authors acknowledge Dept. of Pharmaceutical Technology and Dept. of Biosciences, JIS University, Agarpara, Kolkata for the basic infrastructure facility to carry the research work. The authors also acknowledge Mr. Subhasis Chakraborty, Assistant Professor, DmbHInstitute of Medical Science & Dr. Yadu Nandan Day, Professor, Dr. B. C. Roy College of Pharmacy and Allied Health Sciences for his support.

Funding

The authors received no funding for carrying out the research work.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, JIS University, Kolkata, 700109, West Bengal, India

    Anuva Samanta, Adarsha Ghosh, Southik Nandi, Soumyadeep Ghosh, Akash Gupta, Arijit Mondal, Rudranil Saha, Pranee Roy & Arindam Maity

  2. Department of Biosciences, JIS University, Kolkata, 700109, West Bengal, India

    Dibyarupa Pal

Authors
  1. Anuva Samanta
    View author publications

    Search author on:PubMed Google Scholar

  2. Adarsha Ghosh
    View author publications

    Search author on:PubMed Google Scholar

  3. Southik Nandi
    View author publications

    Search author on:PubMed Google Scholar

  4. Soumyadeep Ghosh
    View author publications

    Search author on:PubMed Google Scholar

  5. Akash Gupta
    View author publications

    Search author on:PubMed Google Scholar

  6. Arijit Mondal
    View author publications

    Search author on:PubMed Google Scholar

  7. Rudranil Saha
    View author publications

    Search author on:PubMed Google Scholar

  8. Pranee Roy
    View author publications

    Search author on:PubMed Google Scholar

  9. Dibyarupa Pal
    View author publications

    Search author on:PubMed Google Scholar

  10. Arindam Maity
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Dibyarupa Pal or Arindam Maity.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download DOCX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samanta, A., Ghosh, A., Nandi, S. et al. Facile synthesis of Sarcochlamys pulcherrima mediated silver nanoparticles for antibacterial, antibiofilm, and network pharmacology evaluation. Sci Rep (2026). https://doi.org/10.1038/s41598-026-51567-y

Download citation

  • Received: 18 February 2026

  • Accepted: 28 April 2026

  • Published: 09 May 2026

  • DOI: https://doi.org/10.1038/s41598-026-51567-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Sp-AgNPs
  • Antibacterial
  • MIC
  • MBC
  • Biofilm inhibition
  • LC-MS/MS
  • Network pharmacology
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research